As of Jun 06
| -0.01 / -0.39%|
The 5 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 10.00, with a high estimate of 17.00 and a low estimate of 2.00. The median estimate represents a +293.70% increase from the last price of 2.54.
The current consensus among 7 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.